Revenue (Tables)

3 Months Ended

Mar. 31, 2025

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue

The following tables disaggregate our revenue from contracts with customers by business unit and geographic region (in millions). Generally, we allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.

	Three Months Ended March 31,
	2025						2024
Businesses	U.S.		Int'l		Total		U.S.		Int'l		Total
Endoscopy	$	420	$	253	$	673	$	395	$	247	$	642
Urology	469		165		633		356		157		513
Neuromodulation	204		67		271		190		66		256
MedSurg	1,093		484		1,577		941		470		1,412
Interventional Cardiology Therapies	232		465		697		195		457		652
Watchman	390		34		425		311		33		344
Cardiac Rhythm Management	358		220		578		354		221		575
Electrophysiology	511		219		730		158		143		300
Cardiology	1,491		938		2,429		1,017		854		1,872
Peripheral Interventions	376		280		656		299		274		573
Cardiovascular	1,868		1,218		3,085		1,316		1,129		2,445
Total Net Sales	$	2,960	$	1,702	$	4,663	$	2,258	$	1,599	$	3,856

Refer to Note J – Segment Reporting for information on our reportable segments.

	Three Months Ended March 31,
Geographic Regions	2025		2024
U.S.	$	2,960	$	2,258
Europe, Middle East and Africa	846		803
Asia-Pacific	701		647
Latin America and Canada	155		149
Total Net Sales	$	4,663	$	3,856
Emerging Markets(1)	$	690	$	648